Chapter 19 : Osteomyelitis

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Osteomyelitis, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818104/9781555811594_Chap19-1.gif /docserver/preview/fulltext/10.1128/9781555818104/9781555811594_Chap19-2.gif


Different types of osteomyelitis can be classified according to the source of the infection (i.e., hematogenous or contiguous focus) and the vascular capability of the host (i.e., with or without generalized vascular insufficiency). Due to the abundant vascular supply, the most common sites of hematogenous osteomyelitis are the metaphyses of tubular bones. The major types of hematogenous osteomyelitis seen clinically include long-bone and vertebral osteomyelitis. Chronic vertebral osteomyelitis arises most often in those patients that have predisposing factors, such as the use of nonsterile injection techniques by intravenous drug abusers, previous spinal surgery, or implanted hardware. All three mechanisms may cause skin ulceration with subsequent skin infection, which may lead to contiguous-focus osteomyelitis. Staphylococcal products that have a role in osteomyelitis may be classified as virulence factors responsible for adherence, direct host damage, or immune avoidance. Clinical strains of spp. are able to persist through a number glycocalyx properties. First, this layer has been shown to protect the embedded pathogens from the action of antimicrobial agents and the host immune system by forming a mechanical barrier. Second, local immune deficiency often occurs through frustrated phagocytosis, since the normal phagocytic processes are devoted to the removal of the glycocalyx and the implant, if present. Different types of chronic osteomyelitis can be classified according to the source of the infection (i.e., hematogenous or contiguous focus) and the vascular capability of the host (i.e., with or without generalized vascular insufficiency).

Citation: Shirtliff M, Mader J. 2000. Osteomyelitis, p 375-396. In Nataro J, Blaser M, Cunningham-Rundles S (ed), Persistent Bacterial Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818104.ch19

Key Concept Ranking

Toxic Shock Syndrome Toxin 1
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Akiyama, H.,, R. Torigoe,, and J. Arata. 1993. Interaction o f Staphylococcus aureus cells and silk threads in vitro and in mouse skin. J. Dermatol. Sci. 6:247257.
2. Akiyama, H.,, M. Ueda,, H. Kanzaki,, J. Tada,, and j. Arata. 1997. Biofilm formation o f Staphylococcus aureus strains isolated from impetigo and furuncle: role of fibrinogen and fibrin. J. Dermatol. Sci. 16:210.
3. Alam, S. I.,, K. A. Khan,, and A. Ahmad. 1990. Glycocalyx positive bacteria isolated from chronic osteomyelitis and septic arthritis. Ceylon Med. J. 35:2123.
4. Albus, A.,, R. D. Arbeit,, and J. C. Lee. 1991. Virulence of Staphylococcus aureus mutants altered in type 5 capsule production. Infect. Immun. 59: 10081014.
5. Arvand, M.,, S. Bhakdi,, B. Dahlback,, and K. T. Preissner. 1990. Staphylococcus aureus alphatoxin attack on human platelets promotes assembly of the prothrombinase complex. J. Biol. Chem. 265:1437714381.
6. Balaban, N.,, T. Goldkorn,, R. T. Nhan,, L. B. Dang,, S. Scott,, R. M. Ridgley,, A. Rasooly,, S. C. Wright,, J. W. Larrick,, R. Rasooly,, and j. R. Carlson. 1998. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 280:438440.
7. Batson, O. V. 1940. The function of the vertebral veins and their role in the spread of metastases. Ann. Surg. 112:138140.
8. Bayer, A. S.,, P. M. Sullam,, M. Ramos,, C. Li,, A. L. Cheung,, and M. R. Yeaman. 1995. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect. Immun. 63:36343641.
8a. Bayles, K. W.,, C. A. Wesson,, L. E. Liou,, L. K. Fox,, G. A. Bohach,, and W. R. Trumble. 1998. Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect. Immun. 66:336342.
9. Ben-Yehuda, A., and M. E. Weksler. 1992. Host resistance and the immune system. Clin. Geriatr. Med. 8:701711.
10. Boden, M. K.,, and J. I. Flock. 1994. Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus. Mol. Microbiol. 12:599606.
11. Bowerman, S. G.,, N. E. Green,, and G. A. Mencio. 1997. Decline of bone and joint infections attributable to Haemophilus influenzae type b. Clin. Orthop. Relat. Res. 341:128133.
12. Brause, B. D. 1986. Infections associated with prosthetic joints. Clin. Rheum. Dis. 12:523536.
13. Buckholz, J. M. 1987. The surgical management of osteomyelitis: with special reference to a surgical classification. J. Foot Surg. 26:S17S24.
14. Buxton, T. B.,, J. P. Rissing,, J. A. Horner,, K. M. Plowman,, D. F. Scott,, T. J. Sprinkle,, and G. K. Best. 1990. Binding of a Staphylococcus aureus bone pathogen to type I collagen. Microb. Pathog. 8:441448.
15. Calhoun, J. H.,, J. Cantrell,, J. Cobos,, J. Lacy,, R. R. Valdez,, J. Hokanson,, and J. T. Mader. 1988. Treatment of diabetic foot infections: Wagner classification, therapy, and outcome. Foot Ankle 9:101106.
16. Caputo, G. M.,, P. R. Cavanagh,, J. S. Ulbrecht,, G. W. Gibbons,, and A. W. Karchmer. 1994. Assessment and management of foot disease in patients with diabetes. N. Engl. J. Med. 331:854860.
17. Chan, P. F.,, and S. J. Foster. 1998. Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus. J. Bacteriol. 180:62326241.
18. Cheung, A. I.,, S. J. Projan,, R. E. Edelstein,, and V. A. Fischetti. 1995. Cloning, expression, and nucleotide sequence of a Staphylococcus aureus gene (fbpA) encoding a fibrinogen-binding protein. Infect. Immun. 63:19141920.
19. Cheung, A. L.,, M. G. Bayer,, and J. H. Heinrichs. 1997. sar genetic determinants necessary for transcription of RNAII and RNAIII in the agr locus of Staphylococcus aureus. J. Bacteriol. 179: 39633971.
20. Cheung, A. L.,, Y. T. Chien,, and A. S. Bayer. 1999. Hyperproduction of alpha-hemolysin in a sigB mutant is associated with elevated SarA expression in Staphylococcus aureus. Infect. Immun. 67:13311337.
21. Cierny, G.,, and J. T. Mader. 1987. Approach to adult osteomyelitis. Orthop. Rev. 16:259270.
22. Crock, H. V.,, and M. Goldwasser. 1984. Anatomic studies of the circulation in the region of the vertebral end-plate in adult Greyhound dogs. Spine 9:702706.
23. Dassy, B.,, T. Hogan,, T. J. Foster,, and J. M. Fournier. 1993. Involvement of the accessory gene regulator (agr) in expression o f type 5 capsular polysaccharide by Staphylococcus aureus. J. Gen. Microbiol. 139:13011306.
24. DeJonghe, M.,, and G. Glaesener. 1995. Type B Haemophilus influenzae infections. Experience at the Pediatric Hospital o f Luxembourg. Bull. Soc. Sci. Med. Grand-Duche Luxemb. 132:1720. (In French.)
25. Deora, R.,, and T. K. Misra. 1996. Characterization of the primary sigma factor o f Staphylococcus aureus. J. Biol. Chem. 271:2182821834.
26. Donabedian, H.,, and J. I. Gallin. 1983. The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the N IH experience and the literature. Medicine 62:195208.
27. Dougherty, S. H.,, and R. L. Simmons. 1989. Endogenous factors contributing to prosthetic device infections. Infect. Dis. Clin. N. Am. 3:199209.
27a. Ellington, J. K.,, S. S. Reffly,, W. K. Ramp,, M. S. Smeltzer,, J. F. Kellam,, and M. C. Hudson. 1999. Mechanisms of Staphylococcus aureaus invasion of cultured osteoblasts. Microb. Pathog. 26:317323.
28. Espersen, F.,, N. Frimodt-Moller,, R. V. Thamdrup,, P. Skinhoj,, and M. W. Bentzon. 1991. Changing pattern of bone and joint infections due to Staphylococcus aureus: study of cases of bacteremia in Denmark, 1959-1988. Rev. Infect. Dis. 13:347358.
29. Essawi, T.,, T. Na’was,, A. Hawwari,, S. Wadi,, A. Doudin,, and A. I. Fattom. 1998. Molecular, antibiogram and serological typing of Staphylococcus aureus isolates recovered from Al-Makased Hospital in East Jerusalem. Trop. Med. Int. Health 3:576583 .
30. Evans, P.,, and L. Hofmann. 1994. Malignant external otitis: a case report and review. Am. Fam. Physician 49:427431.
31. Evans, R. P.,, C. L. Nelson,, W. R. Bowen,, M. G. Kleve,, and S. G. Hickmon. 1998. Visualization ofbacterial glycocalyx with a scanning electron microscope. Clin. Orthop. Relat. Res. 347:243249.
32. Ferguson, D. A. J.,, E. M. Veringa,, W. R. Mayberry,, B. P. Overbeek,, D. W. Lambe, Jr.,, and J. Verhoef. 1992. Bacteroides and Staphylococcus glycocalyx: chemical analysis, and the effects on chemiluminescence and chemotaxis of human polymorphonuclear leucocytes. Microbios 69: 5365.
33. Ferreras, M.,, F. Hoper,, S. M. Dalla,, D. A. Colin,, G. Prevost,, and G. Menestrina. 1998. The interaction of Staphylococcus aureus bi-component gamma-hemolysins and leucocidins with cells and lipid membranes. Biochim. Biophys. Acta 1414:108126.
34. Fischer, B.,, P. Vaudaux,, M. Magnin,, Y. el Mestikawy,, R. A. Proctor,, D. P. Lew,, and H. Vasey. 1996. Novel animal model for studying the molecular mechanisms of bacterial adhesion to bone-implanted metallic devices: role of fibronectin in Staphylococcus aureus adhesion. J. Orthop. Res. 14:914920.
35. Francois, P.,, P. Vaudaux,, and P. D. Lew. 1998. Role of plasma and extracellular matrix proteins in the physiopathology of foreign body infections. Ann. Vase. Surg. 12:3440.
36. Gill, P. J.,, E. Goddard,, D. W. Beatty,, and E. B. Hoffman. 1992. Chronic granulomatous disease presenting with osteomyelitis: favorable response to treatment with interferon-gamma. J. Pediatr. Orthop. 12:398400.
37. Gillaspy, A. F.,, C. Y. Lee,, S. Sau,, A. L. Cheung,, and M. S. Smeltzer. 1998. Factors affecting the collagen binding capacity of Staphylococcus aureus. Infect. Immun. 66:31703178.
38. Giraudo, A. T.,, H. Rampone,, A. Calzolari,, and R. Nagel. 1996. Phenotypic characterization and virulence of a sae- agr- mutant of Staphylococcus aureus. Can. J. Microbiol. 42:120123.
39. Gouaux, E.,, M. Hobaugh,, and L. Song. 1997. Alpha-hemolysin, gamma-hemolysin, and leukocidin from Staphylococcus aureus: distant in sequence but similar in structure. Protein Sci. 6: 26312635.
40. Grimminger, F.,, F. Rose,, U. Sibelius,, M. Meinhardt,, B. Potzsch,, R. Spriestersbach,, S. Bhakdi,, N. Suttorp,, and W. Seeger. 1997. Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alphatoxin. J. Immunol. 159:19091916.
41. Gristina, A. G.,, M. Oga,, L. X. Webb,, and C. D. Hobgood. 1985. Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science 228:990993.
42. Groll, A.,, and P. M. Shah. 1989. Teichoic acid antibody assay in infections of the bones and joints caused by Staphylococcus aureus. Unfallchirurg 92:414418. (In German.)
43. Heilmann, C.,, O. Schweitzer,, C. Gerke,, N. Vanittanakom,, D. Mack,, and F. Gotz. 1996. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol. Microbiol. 20:10831091.
44. Herrmann, M.,, P. E. Vaudaux,, D. Pittet,, R. Auckenthaler,, P. D. Lew,, F. Schumacher- Perdreau,, G. Peters,, and F. A. Waldvogel. 1988. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J. Infect. Dis. 158: 693701.
45. Hildebrand, A.,, M. Pohl,, and S. Bhakdi. 1991. Staphylococcus aureus alpha-toxin. Dual mechanism o f binding to target cells. J. Biol. Chem. 266:1719517200.
46. Hobo, T. 1922. Zur Pathogenese der akuten haematogenen Osteomyelitis, mit Berucksichtigung der Vitalfarbungslehre. Acta Sch. Med. Univ. Imp. Kioto 4:129.
47. Holzman, R. S.,, and F. Bishko. 1971. Osteomyelitis in heroin addicts. Ann. Intern. Med. 75:693696.
48. Hudson, M. C.,, W. K. Ramp,, N. C. Nicholson,, A. S. Williams,, and M. T. Nousiainen. 1995. Internalization of Staphylococcus aureus by cultured osteoblasts. Microb. Pathog. 19:409419.
48a. Hultgren, O.,, M. Kopf,, and A. Tarkowski. 1999. Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4 deficient mice depends on the genetic background of the host. Eur. J. Immunol 29:24002405.
49. Hussain, M.,, M. H. Wilcox,, and P. J. White. 1993. The slime of coagulase-negative staphylococci: biochemistry and relation to adherence. FEMS Microbiol Rev. 10:191207.
50. Ish-Horowicz, M. R.,, P. McIntyre,, and S. Nade. 1992. Bone and joint infections caused by multiply resistant Staphylococcus aureus in a neonatal intensive care unit. Pediatr. Infect. Dis. J. 11: 8287.
51. Jackson, M. A.,, and j. D. Nelson. 1982. Etiology and medical management of acute suppurative bone and joint infections in pediatric patients. J. Pediatr. Orthop. 2:313323.
52. Ji, G.,, R. Beavis,, and R. P. Novick. 1997. Bacterial interference caused by autoinducing peptide variants. Science 276:20272030.
53. Johnson, M. P.,, and R. Ramphal. 1990. Malignant external otitis: report on therapy with ceftazidime and review of therapy and prognosis. Rev. Infect. Dis. 12:173180.
54. Jonsson, K.,, C. Signas,, H. P. Muller,, and M. Lindberg. 1991. Two different genes encode fibronectin binding proteins in Staphylococcus aureus. The complete nucleotide sequence and characterization of the second gene. Eur. J. Biochem. 202:10411048.
55. Khachapuridze, G. G.,, S. G. Nergadze,, N. N. Lapiashvili,, I. N. Panieva,, L. S. Barenfel’d,, N. M. Pleskach,, and M. S. Imedadze. 1991. The effect of staphylococcal alpha-toxin on D N A rephcation in human cells. Tsitologiia 33: 8289. (In Russian.)
56. Kharbanda, Y.,, and R. S. Dhir. 1991. Natural course of hematogenous pyogenic osteomyelitis (a retrospective study of 110 cases). J. Postgrad. Med. 37:6975.
57. Konig, B.,, G. Prevost,, and W. Konig. 1997. Composition of staphylococcal bi-component toxins determines pathophysiological reactions. J. Med. Microbiol. 46:479485.
58. Kuypers, J. M.,, and R. A. Proctor. 1989. R e duced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect. Immun. 57:23062312.
58a. Lammers, A.,, P. J. Nuijten,, and H. E. Smith. 1999. The fibronectin binding proteins of Staphylococcus aureus are required for adhesion to and invasion of bovine mammary gland cells. FEMS Microbiol Lett. 180:103109.
59. Lee, J. C.,, S. Takeda,, P. J. Livolsi,, and L. C. Paoletti. 1993. Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus. Infect. Immun. 61:18531858.
60. Lew, D. P.,, and F. A. Waldvogel. 1997. Osteomyelitis. N. Engl. J. Med. 336:9991007.
61. Li, S.,, S. Arvidson,, and R. Mollby. 1997. Variation in the agr-dependent expression of alpha-toxin and protein A among clinical isolates of Staphylococcus aureus from patients with septicaemia. FEMS Microbiol Lett. 152:155161.
62. Lina, G.,, S. Jarraud,, G. Ji,, T. Greenland,, A. Pedraza,, J. Etienne,, R. P. Novick,, and F. Vandenesch. 1998. Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus. Mol. Microbiol. 28:655662.
63. Littlewood-Evans, A. J.,, M. R. Hattenberger,, C. Luscher,, A. Pataki,, O. Zak,, and T. O'Reilly. 1997. Local expression of tumor necrosis factor alpha in an experimental model of acute osteomyelitis in rats. Infect. Immun. 65: 34383443.
64. Lopes, J. D.,, G. F. Da-Mota,, C. R. Carneiro,, L. Gomes,, F. Costa-e-Silva-Filho,, and R. R. Brentani. 1988. Evolutionary conservation of laminin-binding proteins. Braz. J. Med. Biol. Res. 21:12691273.
65. Lopes, J. D.,, M. dos Reis,, and R. R. Brentani. 1985. Presence of laminin receptors in Staphylococcus aureus. Science 229:275277.
66. Lowe, A. M.,, D. T. Beattie,, and R. L. Deresiewicz. 1998. Identification of novel staphylococcal virulence genes by in vivo expression technology. Mol Microbiol 27:967976.
67. Mader, J. T.,, G. L. Brown,, J. C. Guckian,, C. H. Wells,, and J. A. Reinarz. 1980. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J. Infect. Dis. 142:915922.
68. Mader, J. T.,, M. Ortiz,, and J. H. Calhoun. 1996. Update on the diagnosis and management of osteomyelitis. Clin. Podiatr. Med. Surg. 13:701724.
69. Martin, D.,, L. G. Mathieu,, J. Lecomte,, and J. deRepentigny. 1986. Adherence of gram-positive and gram-negative bacterial strains to human lung fibroblasts in vitro. Exp. Biol. 45:323334.
70. McDevitt, D.,, P. Francois,, P. Vaudaux,, and T. J. Foster. 1994. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 11:237248.
71. McDevitt, D.,, P. Vaudaux,, and T. J. Foster. 1992. Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect. Immun. 60:15141523.
72. McGavin, M. H.,, D. Krajewska-Pietrasik,, C. Ryden,, and M. Hook. 1993. Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity. Infect. Immun. 61:24792485.
73. McKenney, D.,, J. Hubner,, E. Muller,, Y. Wang,, D. A. Goldmann,, and G. B. Pier. 1998. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/ adhesin. Infect. Immun. 66:47114720.
74. Mempel, M.,, E. Muller,, R. Hoffmann,, H. Feucht,, R. Laufs,, and L. Gruter. 1995. Variable degree o f slime production is linked to different levels o f beta-lactam susceptibility in Staphylococcus epidermidis phase variants. Med. Microbiol. Immunol. 184:109113.
74a. Menzies, B. E.,, and I. Kourteva. 1998. Internalization of Staphylococcus aureus by endothelial cells induces apoptosis. Infect. Immun. 66: 59945998.
75. Modun, B.,, D. Kendall,, and P. Williams. 1994. Staphylococci express a receptor for human transferrin: identification of a 42-kilodalton cell wall transferrin-binding protein. Infect. Immun. 62:38503858.
76. Moreillon, P.,, J. M. Entenza,, P. Francioli,, D. McDevitt,, T. J. Foster,, P. Francois,, and P. Vaudaux. 1995. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Immun. 63:47384743.
76a. Morfeldt, E.,, K. Tegmark,, and S. Arvidson. 1996. Transcriptional control of the agr-dependent virulence gene regulator. Mol. Microbiol. 21:12271237.
77. Naidu, A. S.,, M. Andersson,, and A. Forsgren. 1992. Identification of a human lactoferrin-binding protein in Staphylococcus aureus. J. Med. Microbiol. 36:177183.
78. Na’was, T.,, A. Hawwari,, E. Hendrix,, J. Hebden,, R. Edelman,, M. Martin,, W. Campbell,, R. Naso,, R. Schwalbe,, and A. I. Fattom. 1998. Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients. J. Clin. Microbiol. 36:414420.
79. Nilsson, I. M.,, T. Bremell,, C. Ryden,, A. L. Cheung,, and A. Tarkowski. 1996. Role of the staphylococcal accessory gene regulator (sar) in septic arthritis. Infect. Immun. 64:44384443.
79a. Novick, R. P.,, S. Projan,, J. Kornblum,, H. Ross,, B. Kreiswirth,, and S. Moghazeh. 1995. The agr P-2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol. Gen. Genet. 248:446458.
80. Park, P. W.,, J. Rosenbloom,, W. R. Abrams,, and R. P. Mecham. 1996. Molecular cloning and expression o f the gene for elastin-binding protein (ebpS) in Staphylococcus aureus, J. Biol. Chem. 271:1580315809.
81. Patel, A. H.,, J. Kornblum,, B. Kreiswirth,, R. Novick,, and T. J. Foster. 1992. Regulation of the protein A-encoding gene in Staphylococcus aureus. Gene 114:2534.
82. Patel, A. H.,, P. Nowlan,, E. D. Weavers,, and T. Foster. 1987. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect. Immun. 55:31033110.
83. Patti, J. M.,, H. Jonsson,, B. Guss,, L. M. Switalski,, K. Wiberg,, M. Lindberg,, and M. Hook. 1992. Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin. J. Biol. Chem. 267: 47664772.
84. Pesanti, E. L.,, and J. A. Lorenzo. 1998. Osteoclasts and effects of interleukin 4 in development of chronic osteomyelitis. Clin. Orthop. Rel. Res. 355:290299.
85. Piriz, D. S.,, F. H. Kayser,, and B. Berger- Bachi. 1996. Impact o f sar and agr on methicillin resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 141:255260.
86. Prevost, G.,, B. Cribier,, P. Couppie,, P. Petiau,, G. Supersac,, V. Finck-Barbancon,, H. Monteil,, and Y. Piemont. 1995. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect. Immun. 63:41214129.
87. Rao, L.,, R. K. Karls,, and M. J. Betley. 1995. In vitro transcription of pathogenesis-related genes by purified R N A polymerase from Staphylococcus aureus. J. Bacteriol. 177:26092614.
88. Regassa, L. B.,, R. P. Novick,, and M. J. Betley. 1992. Glucose and nonmaintained pH decrease expression of the accessory gene regulator (agr) in Staphylococcus aureus. Infect. Immun. 60: 33813388.
89. Renno, T.,, M. Hahne,, and H. R. MacDonald. 1995. Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J. Exp. Med. 181:22832287.
90. Roisman, F. R.,, D. T. Walz,, and A. E. Finkelstein. 1983. Superoxide radical production by human leukocytes exposed to immune complexes: inhibitory action of gold compounds. Inflammation 7:355362.
91. Ryden, C.,, H. S. Tung,, V. Nikolaev,, A. Engstrom,, and A. Oldberg. 1997. Staphylococcus aureus causing osteomyelitis binds to a nonapeptide sequence in bone sialoprotein. Biochem. J. 327:825829.
92. Santavirta, S.,, Y. T. Konttinen,, V. Bergroth,, and M. Gronblad. 1991. Lack of immune response to methyl methacrylate in lymphocyte cultures. Acta Orthop. Scand. 62:2932.
93. Santavirta, S.,, Y. T. Konttinen,, T. Saito,, M. Gronblad,, E. Partio,, P. Kemppinen,, and P. Rokkanen. 1990. Immune response to polyglycolic acid implants. J. Bone Joint Surg. Br. 72:597600.
94. Sapico, F. L. 1996. Microbiology and antimicrobial therapy of spinal infections. Orthop. Clin. N. Am. 27:913.
95. Sapico, F. L.,, and J. Z. Montgomerie. 1979. Pyogenic vertebral osteomyelitis: report of nine cases and review of the literature. Rev. Infect. Dis. 1:754776.
96. Sapico, F. L.,, and J. Z. Montgomerie,. 1986. Vertebral osteomyelitis, p. 14791481. In A. I. Braude,, C. E. Davis,, and J. Fierer (ed.), Infectious Diseases and Medical Microbiology. W. B. Saunders Co., Philadelphia, Pa.
97. Schlievert, P. M. 1993. Role of superantigens in human disease. J. Infect. Dis. 167:9971002.
98. Schmitz, F. J.,, K. E. Veldkamp,, K. P. Van Kessel,, J. Verhoef,, and J. A. Van Strijp. 1997. Delta-toxin from Staphylococcus aureus as a costimulator of human neutrophil oxidative burst. J. Infect. Dis. 176:15311537.
99. Sharp, J. F.,, J. A. Wilson,, L. Ross,, and R. M. Barr-Hamilton. 1990. Ear wax removal: a survey of current practice. BMJ 301:12511253.
100. Smith, J. A.,, and J. J. O’Connor. 1996. Nasal carriage of Staphylococcus aureus in diabetes mellitus. Lancet ii:776777.
101. Sourmelis, S. G.,, F. D. Burke,, and J. P. Varian. 1986. A review of total elbow arthroplasty and an early assessment of the Liverpool elbow prosthesis. J. Hand Surg. (Br.) 11:407413.
102. Stout, R. D.,, K. P. Ferguson,, Y. N. Li,, and D. W. Lambe, Jr. 1992. Staphylococcal exopolysaccharides inhibit lymphocyte proliferative responses by activation of monocyte prostaglandin production. Infect. Immun. 60:922927.
103. Switalski, L. M.,, J. M. Patti,, W. Butcher,, A. G. Gristina,, P. Speziale,, and M. Hook. 1993. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol. Microbiol. 7:99107.
104. Tauber, A. I.,, N. Borregaard,, E. Simons,, and j. Wright. 1983. Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies. Medicine 62:286309.
105. Tokunaga, H.,, and T. Nakae. 1992. Calcium ion-mediated regulation of the alpha-2 toxin pore of Staphylococcus aureus. Biochim. Biophys. Acta 1105:125130.
106. Tomita, T.,, and Y. Kamio. 1997. Molecular biology of the pore-forming cytolysins from Staphylococcus aureus, alpha- and gamma-hemolysins and leukocidin. Biosci. Biotechnol. Biochem. 61:565572.
107. Tremaine, M. T.,, D. K. Brockman,, and M. J. Betley. 1993. Staphylococcal enterotoxin A gene (sea) expression is not affected by the accessory gene regulator (agr). Infect. Immun. 61:356359.
108. Trueta, J.,, and J. D. Morgan. 1960. The vascular contribution to osteogenesis. Studies by the injection method. J. Bone Joint Surg. 42B:97109.
109. Vakil, B. V.,, N. Ramakrishnan,, and D. S. Pradhan. 1984. Identification of a heat-labile cellular nuclease in Staphylococcus aureus with properties similar to the extracellular nuclease. Arch. Microbiol. 139:240244.
110. Vandenesch, F.,, S.J. Projan,, B. Kreiswirth,, J. Etienne,, and R. P. Novick. 1993. Agr-related sequences in Staphylococcus lugdunensis. FEMS Microbiol. Lett. 111:115122.
111. van der Vijver, J. M.,, M. M. van Es-Boon,, and M. F. Michel. 1975. A study of virulence factors with induced mutants of Staphylococcus aureus. J. Med. Microbiol. 8:279287.
112. Van Wamel, W. J.,, G. van Rossum,, J. Verhoef,, C. M. Vandenbroucke-Grauls,, and A. C. Fluit. 1998. Cloning and characterization of an accessory gene regulator (agr)-tike locus from Staphylococcus epidermidis. FEMS Microbiol. Lett. 163:19.
113. Veenstra, G. J.,, F. F. Cremers,, H. v andijk,, and A. Fleer. 1996. Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis. J. Bacteriol. 178:537541.
114. Waldvogel, F. A.,, G. Medoff,, and M. N. Swartz. 1970. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N. Engl. J. Med. 282:260266. (Second of three parts.)
115. Waldvogel, F. A.,, G. Medoff,, and M. N. Swartz. 1970. Osteomyelitis: a review o f clinical features, therapeutic considerations and unusual aspects. N. Engl.J. Med. 282:198206. (First of three parts.)
116. Waldvogel, F. A.,, G. Medoff,, and M. N. Swartz. 1970. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency. N. Engl. J. Med. 282:316322.
117. Walev, I.,, U. Weller,, S. Strauch,, T. Foster,, and S. Bhakdi. 1996. Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus. Inject. Immun. 64:29742979.
118. Wang, J. Y.,, B. H. Wicklund,, R. B. Gustilo,, and D. T. Tsukayama. 1997. Prosthetic metals impair murine immune response and cytokine release in vivo and in vitro. J. Orthop. Res. 15: 688699.
119. Weber, M. L.,, A. Abela,, L. de Repentigny,, L. Garel,, and N. Lapointe. 1987. Myeloperoxidase deficiency with extensive candidal osteomyelitis of the base of the skull. Pediatrics 80:876879.
120. White, C. J.,, and J. I. Gallin. 1986. Phagocyte defects. Clin. Immunol. Immunopathol. 40:5061.
121. Wiley, A. M.,, and J. Trueta. 195. The vascular anatomy of the spine and its relationship to pyogenic vertebral osteomyelitis. J. Bone Joint Surg. 41B:796804.
122. Yacoub, A.,, P. Lindahl,, K. Rubin,, M. Wendel,, D. Heinegard,, and C. Ryden. 1994. Purification of a bone sialoprotein-binding protein from Staphylococcus aureus. Eur. J. Biochem. 222:919925.
123. Yoon, K. S.,, R. H. Fitzgerald,, S. Sud,, Z. Song,, and P. H. Wooley. 1999. Experimental acute hematogenous osteomyelitis in mice. II. Influence of Staphylococcus aureus infection o n T-cell immunity. J. Orthop. Res. 17:382391.


Generic image for table

Systemic and local factors that affect immune surveillance, metabolism, and local vascularity

Citation: Shirtliff M, Mader J. 2000. Osteomyelitis, p 375-396. In Nataro J, Blaser M, Cunningham-Rundles S (ed), Persistent Bacterial Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818104.ch19

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error